QQ客服 官方微博 反馈留言

	Anti-IGF-1R monoclonal antibody inhibits the carcinogenicity activity of acquired trastuzumab-resistant SKOV3
	Wang, Wei[1]; Zhang, Yan[2]; Lv, Ming[3]; Feng, Jiannan[4]; Peng, Hui[5]; Geng, Jing[6]; Lin, Zhou[7]; Zhou, Tingting[8]; Li, Xinying[9]; Shen, Beifen[10]
刊名	JOURNAL OF OVARIAN RESEARCH
	2014
卷号	7页码:103
关键词	IGF-1R Monoclonal antibody Acquired resistant Trastuzumab Ovarian cancer
ISSN号	1757-2215
DOI	http://dx.doi.org/10.1186/s13048-014-0103-5
URL标识	查看原文
收录类别	SCI(E) ; PUBMED
WOS记录号	WOS:000346099600001
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5220975
专题	河南大学
作者单位	1.[1]Henan Univ, Inst Immunol, Lab Cellular & Mol Immunol, Kaifeng 475001, Peoples R China. 2.Inst Basic Med Sci, Immunol Lab, Beijing 100850, Peoples R China. 3.[2]Peoples Liberat Army Gen Hosp, Dept Gynecol & Obstet, Beijing 100853, Peoples R China. 4.[3]Inst Basic Med Sci, Immunol Lab, Beijing 100850, Peoples R China. 5.[4]Henan Univ, Inst Immunol, Lab Cellular & Mol Immunol, Kaifeng 475001, Peoples R China. 6.Inst Basic Med Sci, Immunol Lab, Beijing 100850, Peoples R China. 7.[5]Tianjin Inst Hlth & Environm Med, Dept Environm & Pharm, Beijing 100850, Peoples R China. 8.[6]Inst Basic Med Sci, Immunol Lab, Beijing 100850, Peoples R China. 9.[7]Inst Basic Med Sci, Immunol Lab, Beijing 100850, Peoples R China. 10.[8]Inst Basic Med Sci, Immunol Lab, Beijing 100850, Peoples R China.
推荐引用方式 GB/T 7714	Wang, Wei[1],Zhang, Yan[2],Lv, Ming[3],et al. Anti-IGF-1R monoclonal antibody inhibits the carcinogenicity activity of acquired trastuzumab-resistant SKOV3[J]. JOURNAL OF OVARIAN RESEARCH,2014,7:103.
APA	Wang, Wei[1].,Zhang, Yan[2].,Lv, Ming[3].,Feng, Jiannan[4].,Peng, Hui[5].,...&Qiao, Chunxia[12].(2014).Anti-IGF-1R monoclonal antibody inhibits the carcinogenicity activity of acquired trastuzumab-resistant SKOV3.JOURNAL OF OVARIAN RESEARCH,7,103.
MLA	Wang, Wei[1],et al."Anti-IGF-1R monoclonal antibody inhibits the carcinogenicity activity of acquired trastuzumab-resistant SKOV3".JOURNAL OF OVARIAN RESEARCH 7(2014):103.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。